Boston Scientific (NYSE: BSX) director adds 4,450 company shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Boston Scientific Corp director David C. Habiger reported buying additional company stock in two recent open-market transactions. He purchased 2,200 shares of Common Stock on May 19, 2026 at a weighted average price of $56.9451 per share, and 2,250 shares on May 20, 2026 at a weighted average price of $55.9195 per share. According to the filing, individual trades on each day occurred within narrow price ranges around these averages. Following these purchases, Habiger directly owns 13,878 Boston Scientific common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,450 shares ($251,098)
Net Buy
2 txns
Insider
Habiger David C
Role
null
Bought
4,450 shs ($251K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,250 | $55.9195 | $126K |
| Purchase | Common Stock | 2,200 | $56.9451 | $125K |
Holdings After Transaction:
Common Stock — 13,878 shares (Direct, null)
Footnotes (1)
- Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.93 to $56.96, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $55.85 to $56.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Key Figures
Total shares bought: 4,450 shares
May 19 purchase: 2,200 shares
May 19 weighted avg price: $56.9451 per share
+3 more
6 metrics
Total shares bought
4,450 shares
Open-market purchases on May 19–20, 2026
May 19 purchase
2,200 shares
Common Stock, open-market on May 19, 2026
May 19 weighted avg price
$56.9451 per share
Trades ranged from $56.93 to $56.96
May 20 purchase
2,250 shares
Common Stock, open-market on May 20, 2026
May 20 weighted avg price
$55.9195 per share
Trades ranged from $55.85 to $56.00
Shares owned after trades
13,878 shares
Direct Common Stock holdings post-transactions
Key Terms
open-market purchase, weighted average purchase price, Common Stock, U.S. Securities and Exchange Commission
4 terms
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average purchase price financial
"Represents the weighted average purchase price. These shares were purchased"
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
U.S. Securities and Exchange Commission regulatory
"provide upon request by the U.S. Securities and Exchange Commission staff"
The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.
FAQ
What insider transactions did Boston Scientific (BSX) disclose for David C. Habiger?
Boston Scientific disclosed that director David C. Habiger bought a total of 4,450 Common Stock shares in open-market transactions on May 19 and 20, 2026. These purchases increased his direct holdings to 13,878 shares, according to the Form 4 filing.
Were David C. Habiger’s Boston Scientific (BSX) trades open-market purchases?
Yes. The filing classifies both transactions as open-market purchases of Common Stock under transaction code P. The shares were bought directly by David C. Habiger, rather than through derivatives or indirect entities, and are reported as non-derivative holdings.
Do the Boston Scientific (BSX) insider trades involve derivative securities?
No. The reported transactions involve only non-derivative Common Stock purchases. The derivative section of the Form 4 shows no option or other derivative transactions, and the derivativeSummary is empty, indicating no derivative exercises or conversions in this particular filing.